Sahajanand Medical Technologies IPO

The last grey market premium reported for the Sahajanand Medical Technologies Limited IPO is ₹42, as of 13 Oct, 10:00 pm. Against the ₹344 upper band that is +12.2%. GMP is an unofficial, unregulated datapoint reported by third parties — not a price, a prediction, or investment advice.

Adding the ₹42 premium to the ₹344 upper band gives an implied price of ₹386. That is only what unregulated grey-market dealers are quoting today; the listing price is discovered on the exchange in the pre-open session on listing day and routinely differs from it.

No. The grey market is an informal, over-the-counter market between private dealers that is not operated or supervised by NSE, BSE or SEBI. No trade settles through a clearing corporation and no dealer is obliged to honour a quote, so the premium can change sharply within a day or disappear after bidding closes.

The premium is checked about every 20 minutes from third-party grey-market reporters while the issue is live. The history table adds a row only when the premium changes, with the date and time it changed, how much it moved and the listing price it implies.

NSE and BSE publish the category-wise bids for every open issue during bidding hours. This page reads that feed and shows the QIB, NII and retail book, plus one row per day so the build-up over the issue can be compared.

Subscription of 2× means bids were received for twice the number of shares offered in that category. When a category is oversubscribed, allotment in it is decided by the registrar under the basis-of-allotment rules — retail by lottery for the minimum lot, for example.

Allotment for the Sahajanand Medical Technologies Limited IPO is expected to be finalised on 21 October 2026, the trading day after the issue closes on 19 October 2026. Under SEBI's T+3 timeline refunds and demat credit follow on 22 October 2026 and the shares list on 23 October 2026. Dates are tentative until the registrar and exchange confirm them.

Allotment is decided and published by the registrar, MUFG Intime India Private Limited — not by the exchange and not by alphave. Open the registrar's IPO allotment page, choose the issue, and enter your PAN, application number or DP ID / client ID. Your bank will also show the blocked amount released if shares were not allotted.

The registrar to the Sahajanand Medical Technologies Limited IPO is MUFG Intime India Private Limited. The registrar processes applications, finalises the basis of allotment with the exchange, and handles refunds.

The amount blocked in your bank account under ASBA or the UPI mandate is released, normally on the day allotment is finalised or the next working day. No shares are credited and nothing further is needed from you.

Bidding for the Sahajanand Medical Technologies Limited IPO opens on 15 October 2026 and closes on 19 October 2026. Exchange bidding runs from 10:00 am to 5:00 pm IST on each day; UPI mandates must be accepted by 5:00 pm on the closing day, and brokers may stop taking bids somewhat earlier.

The shares are scheduled to list on 23 October 2026 on NSE. Trading starts at 10:00 am IST after the special pre-open session that discovers the listing price.

Applications are made through a broker's app or a bank's net banking using ASBA, or by UPI mandate, between 15 October 2026 and 19 October 2026. The amount is only blocked, not debited, until allotment. Retail bids of up to ₹2,00,000 are usually placed at the cut-off price (₹344); a UPI mandate must be approved by 5:00 pm on the closing day.

19 October 2026 is the last day of bidding. Allotment is then expected on 21 October 2026, refunds and demat credit on 22 October 2026, and listing on 23 October 2026 — tentative until confirmed.

The Sahajanand Medical Technologies Limited IPO price band is ₹327 to ₹344 per share. Applications are made at the cut-off price, which is the upper end of the band.

One lot is 43 shares, so a single application at the ₹344 cut-off costs ₹14,792. Retail investors can apply for up to 13 lots within the ₹2,00,000 retail limit.

₹14,792 — one lot of 43 shares at ₹344. Bids in the non-institutional category start above ₹2,00,000 and are made in multiples of the lot.

Sahajanand Medical Technologies Limited is a mainboard issue listing on NSE. The lead manager is Motilal Oswal Investment Advisors Limited.

The issue size is ₹475.5 crore.

Sahajanand Medical Technologies Limited reported revenue of ₹1,210.5 crore in FY2026, as restated in its offer document. The table on this page shows each reported year.

From the restated financial statements in the company's draft and final offer documents filed with SEBI and the exchange. alphave reports them as filed, in ₹ crore, and does not publish a valuation or a view on the issue.

The offer document for the Sahajanand Medical Technologies Limited IPO is linked on this page as filed with the exchange; SEBI and the lead managers also host it.

The Draft Red Herring Prospectus is the document a company files with SEBI before an IPO. It describes the business, the financials, the risk factors, the promoters and how the money raised will be used. The Red Herring Prospectus (RHP) is the version filed just before the issue opens, with the price band and dates added.

We are subject to extensive regulatory requirements in applicable jurisdictions. Any adverse action by any authority against us would negatively impact our ability to offer our products to our clients and adversely impact our business and prospects Our manufacturing facilities are subject to certain risks, including quality control issues, disruptions in infrastructure facilities, and obsolete plant and machinery, which could increase our manufacturing costs or interrupt our operations and adversely impact our reputation, sales and strategies We may not be able to implement our business strategies or sustain and manage our growth The page lists all 8 disclosed risk factors.

The Sahajanand Medical Technologies Limited shares are scheduled to list on 23 October 2026 on NSE. The listing price is discovered in a special pre-open session from 9:00 am and normal trading begins at 10:00 am IST.

Grey-market dealers are quoting a premium of ₹42 over the ₹344 band, which implies ₹386. GMP is an unofficial, unregulated datapoint reported by third parties — not a price, a prediction, or investment advice. The actual listing price is set by demand in the pre-open session.

On listing day the exchange runs a special pre-open session for the new stock from 9:00 am IST in which orders are collected and the listing price is discovered; continuous trading in the shares begins at 10:00 am IST.

Subscription figures are the exchange's own category-wise bids (NSE and BSE), refreshed every 5 minutes while bidding is open and frozen at the final tally after close. GMP is an unofficial grey-market indicator read about once an hour from third-party reporters, each reading timestamped. Price band, lot size, issue size, dates, registrar and lead managers are from the exchange's issue master and the offer document filed with SEBI. Financials and the shareholding pattern are as restated in the offer document; allotment is published only by the registrar, which this page links to. Anchor investor allocations, where shown, are the exchange's anchor allocation file.